Arcutis Biotherapeutics announced on September 22, 2025, a partnership with professional football player Odell Beckham Jr. (OBJ) to launch a campaign titled 'Clear Win for Your Skin'. This initiative aims to raise awareness about seborrheic dermatitis (seb derm), a common, chronic inflammatory skin disease.
Odell Beckham Jr. shared his personal experience with seb derm, describing symptoms like flaking, redness, and itching, and his successful treatment with ZORYVE foam. He emphasized the importance of seeking a proper diagnosis and finding an effective treatment option.
The campaign seeks to empower individuals suffering from seb derm to speak with dermatology specialists. ZORYVE foam 0.3% is indicated for the treatment of seborrheic dermatitis in adult and pediatric patients 9 years of age and older, offering rapid disease clearance and significant itch reduction, and was the first drug approved for seb derm with a new mechanism of action in over two decades.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.